FDA Inspection
Sciegen Pharmaceuticals IncSciegen Pharmaceuticals Inc – FDA Inspection, Sep 16, 2011
Record Details
This FDA Inspection record concerns Sciegen Pharmaceuticals Inc, with an inspection on September 16, 2011, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Sciegen Pharmaceuticals Inc
- Inspection Date
- September 16, 2011
- Product Type
- Drugs
View Company Profile
ID · 3135508b-109c-4a37-8420-6673f388af0c
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 745098
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Sciegen Pharmaceuticals Inc
13| Date | Classification | Office | Project area |
|---|---|---|---|
| May 15, 2026 | Not classified | New York District Office | Drug Quality Assurance |
| December 19, 2025 | NAI | Bioresearch Monitoring | |
| February 20, 2024 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 21, 2023 | OAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| September 2, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Sciegen Pharmaceuticals Inc
- FDA Inspection 1317246 - 2026-05-15
- FDA Inspection 1297968 - 2025-12-19
- FDA Inspection 1229682 - 2024-02-20
- FDA Inspection 1204858 - 2023-04-21
- FDA Inspection 1178870 - 2022-09-02
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.